Skip to main content
SpringerLink
Log in

Understanding Dry Eye Syndrome

  • Chapter
Lacrimal Gland, Tear Film, and Dry Eye Syndromes 3

Part of the book series: Advances in Experimental Medicine and Biology ((AEMB,volume 506))

Abstract

It is my great honor and pleasure to receive the first Claes H. Dohlman award at this, the Third International Conference on the Lacrimal Gland, Tear Film and Dry Eye Syndromes. I would like to sincerely thank all those involved in my selection as the recipient. I feel particularly honored because between 1985–1987 I had a corneal fellowship at the Massachusetts Eye and Ear Infirmary, where Professor Dohlman was the Chairman and my professor (Fig. 1). During my time there, Dr. Kenneth R. Kenyon and Dr. Scheffer Tseng were performing dry eye research and asked me to volunteer for the Schirmer test. I was very surprised to learn that the results of my Schirmer test were 0 mm. The next day I performed the test on myself, and the results confirmed that my Schirmer test was definitely 0 mm in both eyes. My only symptom at the time was “ocular fatigue”, and I never experienced any sensation of dryness. As a result of the tests, I was placed in the dry eye group instead of being a normal control, as I had expected. It was then that I resolved to conduct dry eye research for my own benefit and as well as for others.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 259.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 329.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 329.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Lemp, M.A., 1995, Report of the National Eye Institute/Industry workshop on Clinical Trials in Dry Eyes, Clao J 21:221–32.

    CAS  PubMed  Google Scholar 

  2. Xu, K-P., Katagari, S., Takeuchi, T., and Tsubota, K., 1996, Biopsy of labial salivary glands and lacrimal glands in the diagnosis of Sjogren’s syndrome, J Rheumatology 23:76–82.

    CAS  Google Scholar 

  3. Tsubota, K., Xu, K., Fujihara, T., Katagiri, S., and Takeuchi, T., 1996, Decreased reflex tearing is associated with lymphocytic infiltration in lacrimal glands, J Rheumatology 23:313–20.

    CAS  Google Scholar 

  4. Lemp, M.A., Dohlman, C., and Holly, F., 1970, Corneal dessication despite normal tear volume, Ann Ophthalmol 2:258–61.

    Google Scholar 

  5. Rolando, M., Refojo, M., and Kenyon, K., 1983, Increased tear evaporation in eyes with keratoconjunctivitis sicca, Arch Ophthalmol 101:557–8.

    Article  CAS  PubMed  Google Scholar 

  6. Tsubota, K., and Nakamori, K., 1993, Dry eyes and video display terminals, N Eng J Med 328:584.

    Article  CAS  Google Scholar 

  7. Tsubota K., Nakamori, K., 1995, Effects of ocular surface area and blink rate on tear dynamics, Arch Ophthalmol 113:155–8.

    Article  CAS  PubMed  Google Scholar 

  8. Alfonso, A., Monroy, D., Stern M., Feuer, W., Tseng, S., and Pflugfelder, S., 1999, Correlation of tear fluorescein clearance and Schirmer test scores with ocular irritation symtoms, Ophthalmology 106:803–10.

    Article  Google Scholar 

  9. Alfonso, A., Sobrin, L., Monroy, D., Selzer, M., Lokeshwar, B., and Pflugfelder, S., 1999, Tear fluid gelatinase B activity correlates with IL-1a concentration and fluorescein clearance in ocular rosacea, Invest Ophthalmol Vis Sci 40:2506–12.

    Google Scholar 

  10. Tseng, S.C., and Tsubota, K., 1997, Important concepts for treating ocular surface and tear disorders, Am J Ophthalmol 124:825–35.

    Article  CAS  PubMed  Google Scholar 

  11. Sack, R., Tan, K., and Tan, A., 1992, Diurnal tear cycle: Evidence for a nocturnal inflammatory constitutive tear fluid, Invest Ophthalmol Vis Sci 33:626–40.

    CAS  PubMed  Google Scholar 

  12. de saint Jean, M., Brignole, F., Feldmann, G., Gouet, A., and Baudouin, C., 1999, Interferon-gamma induces apoptosis and expression of inflammation-related proteins in chang conjunctival cells, Invest Ophthalmol Vis Sci 40:2199–212.

    Google Scholar 

  13. Tsubota, K., Fukagawa, K., Fujihara, T., Shimmura, S., Saito, I., Saito, K., and Takeuchi, T., 1999, Regulation of human leukocyte antigen expression in human conjunctival epithelium, Invest Ophthalmol Vis Sci 40:28–34.

    CAS  PubMed  Google Scholar 

  14. Ohashi, Y., Motokura, M., Kinoshita, Y., Mano, T., Watanabe, H., Kinoshita, S., Manabe, R., Oshiden, K., and Yanaihara, C., 1989, Presence of epidermal growth factor in human tears, Invest Ophthalmol Vis Sci 30:1879–87.

    CAS  PubMed  Google Scholar 

  15. Ubels, J., Loley, K., and Rismondo, V., 1986, Retinol secretion by the lacrimal gland, Invest Ophthalmol Vis Sci 27:1261–69.

    CAS  PubMed  Google Scholar 

  16. van Setten, G., Viinikka, L., and Tervo, T., 1989, Epidermal growth factor is a constant component of normal human tear fluid, Graeffe’s Arch Clin Exp Ophthalmol 22:184–7.

    Article  Google Scholar 

  17. van Settten, G., Tervo, T., Tervo, K., and Tarkkanen, A., 1992, Epidermal growth factor (EGF) in ocular fluids: presence, origin and therapeutical considerations, Acta Ophthalmol 202:54–9.

    Google Scholar 

  18. van Setten, G., Macauley, S., Humphresy-Beher, M., Chegini, N., and Schultz, G., 1996, Detection of transforming growth factor-alpha mRNA and protein in rat lacrimal glands and characterzation of transforming growth-alpha in human tears, Invest Ophthalmol Vis Sci 37:166–75.

    PubMed  Google Scholar 

  19. Wilson, S.E., Li, Q., Mohan, R.R., Tervo, T., Vesaluoma, M., Bennett, G.L., Schwall, R., Tabor, K., Kim J, Hargrave, S., 1998, Lacrimal gland growth factors and receptors: lacrimal fibroblastic cells are a source of tear HGF, Adv Exp Med Biol 438:625–8.

    Article  CAS  PubMed  Google Scholar 

  20. Tervo, T., Vesaluoma, M., Bennett, G.L., Schwall, R., Helena, M., Liang, Q., and Wilson, S.E., 1997, Tear hepatocyte growth factor (HGF) availability increases markedly after excimer laser surface ablation, Exp Eye Res 64:501–4.

    Article  CAS  PubMed  Google Scholar 

  21. Wilson, S., 1991, Lacrimal gland epidermal growth factor production and the ocular surface, Am J Ophthalmol 111:763–5.

    Article  CAS  PubMed  Google Scholar 

  22. Yoshino, K., Garg, R., Monroy, D., Ji, Z., and Pflugfelder, S., 1996, Production and secretion of transforming growth factor beta (TGF-B) by the human lacrimal gland, Curr Eye Res 15:615–24.

    Article  CAS  PubMed  Google Scholar 

  23. Tsubota, K., 1992, Schirmer test and nasal stimulation, Current Aspects in Ophthalmology: Elsevier Science Publishers; 201–2.

    Google Scholar 

  24. Tsubota, K., Toda, I., Yagi, Y., Ogawa, Y., Ono, M., and Yoshino, K., 1994, Three different types of dry eye syndrome, Cornea 13:202–9.

    Article  CAS  PubMed  Google Scholar 

  25. Tsubota, K., Tear dynamics and dry eye, 1998, Prog Retin Eye Res 17:565–96.

    Article  CAS  PubMed  Google Scholar 

  26. Tsubota, K., 1994, New approaches to dry eye therapy, International Ophthalmology Clinics 34:115–28.

    Article  CAS  PubMed  Google Scholar 

  27. Tsubota, K., Goto, E., Fujita, H., Inoue, H., Saito, I., and Shimmura, S., 1999, Treatment of dry eye by autologous serum application in Sjogren’s Syndrome, Br J Ophthalmol 83:390–5.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  28. Fox, R., Chan, R., Michelson, J., Belmont, J., and Michelson, P., 1984, Beneficial effect of artificial tears made with autologous serum in patients with keratoconjunctivitis sicca, Arthritis Rheum 27:459–61.

    Article  CAS  PubMed  Google Scholar 

  29. Shimmura, S., Ono, M., Shinozaki, K., Toda, I., Takamura, E., Mashima, Y., and Tsubota, K., 1995, Sodium hyaluronate eye drops in the treatment of dry eyes, Br J Ophthalmol 79:1007–11.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  30. Tsubota, K., Yamada, M., and Urayama, K., 1994, Spectacle side panels and moist inserts for the treatment of dry eye patients, Cornea 13:197–201.

    Article  CAS  PubMed  Google Scholar 

  31. Bacman, S., Leiros, C., Sterin-Borda, L., Hubscher, O., Arana, R., and Borda, E., 1998, Autoantibodies against lacrimal gland Ms muscarinic acetylcholine receptors in patients with primary Sjogren’s syndrome, Invest Ophthalmol Vis Sci 39:151–6.

    CAS  PubMed  Google Scholar 

  32. Borda, E., Camusso, J., Leiros, C., Bacman, S., Hubscher, O., Arana, R., and Sterin-Borda, L., 1996, Circulating antibodies against neonatal cardiac muscarinic acetylcholine receptor in patients with Sjogren’s syndrome, Mol Cell Biochem 163/164:335–41.

    Article  CAS  Google Scholar 

  33. Fujihara, T., Fujita, H., Tsubota, K., Saito, K., Tsuzaka, K., Abe, T., and Takeuchi, T., 1999, Preferential localization of CD8+alphaEB7+ T cells around acinar epithelial cells with apoptosis in patients with Sjogren’s syndrome, J Immunol 163:2226–35.

    CAS  PubMed  Google Scholar 

  34. Saito, I., Haruta, K., Shimuta, M., Inoue, H., Sakurai, H., Yamada, K., Ishimaru, N., Higashiyama, H., Sumida, T., Ishida, H., Suda, T., Noda, T., Hayashi, Y., and. Tsubota, T., 1999, Fas ligand mediated exocrinopathy resembling Sjogren’s syndrome in mice transgenic for IL-10, J Immunol 162:2488–94.

    CAS  PubMed  Google Scholar 

  35. Tsubota, K., Fujita, H., Tsuzaka, K., and Takeuchi, T., 2000, Mikulicz’s disease and Sjogren’s syndrome, Invest Ophthalmol Vis Sci 41:1666–73.

    CAS  PubMed  Google Scholar 

  36. Tsubota, K., Fujita, H., Tadano, K., Takeuchi, T., Nurakami, T., Saito, I., and Hayashi, Y., 2001. Improvement of lacrimal function by topical application of cyclosporin A in murine models of Sjögren’s syndrome, Invest Ophthalmol Vis Sci 42:101–10.

    CAS  PubMed  Google Scholar 

  37. Tsubota, K., Saito, I., Ishimaru, N., and Hayashi, Y., 1998, Use of topical cyclosporin A in a primary Sjogren’s syndrome mouse model, Invest Ophthalmol Vis Sci 39:1551–9.

    CAS  PubMed  Google Scholar 

  38. Agre, P., Bonhivers, M., and Borgnia, M.J., 1998, The aquaporins, blueprints for cellular plumbing systems, J Biol Chem 273:14659–62.

    Article  CAS  PubMed  Google Scholar 

  39. Hirai, S., Ishida, N., Watanabe, K., and Mita, S., 2000, Leakage of aquaporin 5 in the tear of dacryoadenitis mice, Invest Ophthalmol Vis Sci 41:2432–7.

    CAS  PubMed  Google Scholar 

  40. Ishida, N., Maruo, J., Mita, S., 1996, Expression and characterization of lacrimal gland water channels in xenopus oocytes, Bioch Biophysical Res Comm 224:1–4.

    Article  CAS  Google Scholar 

  41. Raina, S., Preston, G., Guggino, W., and Agre, P., 1995, Molecular cloning and characterization of an aquaporin cDNA from salivary, lacrimal and respiratory tissues, J Biol Chem 270:1908–12.

    Article  CAS  PubMed  Google Scholar 

  42. Ma, T., Song, Y., Gillespie, A., Carlson, E.J., Epstein, C.J., and Verkman, A.S., 1999, Defective secretion of saliva in transgenic mice lacking aquaporin-5 water channels, J Biol Chem 274:20071–4.

    Article  CAS  PubMed  Google Scholar 

  43. Tsubota, K., Hirai, S., King, L., Agre, P., and Ishida, N., 2001, Defective cellular trafficking of lacrimal gland aquaporin 5 in Sjogren’s syndrome, The Lancet 357:688–689.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Departments of Ophthalmology, Tokyo Dental College, Ichikawa, Chiba, Japan

    Kazuo Tsubota

  2. Keio University School of Medicine, Tokyo, Japan

    Kazuo Tsubota

Authors
  1. Kazuo Tsubota
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Schepens Eye Research Institute, Boston, Massachusetts, USA

    David A. Sullivan , Darlene A. Dartt  & Rose M. Sullivan ,  & 

  2. Harvard Medical School, Boston, Massachusetts, USA

    David A. Sullivan  & Darlene A. Dartt  & 

  3. Allergan, Inc., Irvine, California, USA

    Michael E. Stern

  4. Tokyo Dental College, Chiba, Japan

    Kazuo Tsubota

  5. Ichikawa General Hospital, Chiba, Japan

    Kazuo Tsubota

  6. University of New Orleans, New Orleans, Louisiana, USA

    B. Britt Bromberg

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Kluwer Academic/Plenum Publishers

About this chapter

Cite this chapter

Tsubota, K. (2002). Understanding Dry Eye Syndrome. In: Sullivan, D.A., Stern, M.E., Tsubota, K., Dartt, D.A., Sullivan, R.M., Bromberg, B.B. (eds) Lacrimal Gland, Tear Film, and Dry Eye Syndromes 3. Advances in Experimental Medicine and Biology, vol 506. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-0717-8_1

Download citation

  • DOI: https://doi.org/10.1007/978-1-4615-0717-8_1

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-5208-2

  • Online ISBN: 978-1-4615-0717-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation